Alzamend Neuro, Inc. SEC filings ALZN
Alzamend Neuro, Inc. has 397 filings in SEC EDGAR's recent list, going back to Jun 22, 2016. Its latest annual report, Form 10-K, was filed on Jul 22, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 10, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (regulation fd disclosure). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRE 14A | Preliminary proxy statement | Aug 28, 2026 | Oct 19, 2026 |
| DEFA14A | Additional proxy material | Feb 26, 2026 | — |
| DEF 14A | Proxy statement | Feb 26, 2026 | Apr 17, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 9, 2026 | Apr 17, 2026 |
| DEFA14A | Additional proxy material | Mar 19, 2025 | — |
| DEFA14A | Additional proxy material | Mar 17, 2025 | — |
| DEF 14A | Proxy statement | Mar 13, 2025 | Apr 25, 2025 |
| PRE 14A | Preliminary proxy statement | Feb 28, 2025 | Apr 25, 2025 |
| DEFA14A | Additional proxy material | Jun 11, 2024 | — |
| DEF 14A | Proxy statement | May 31, 2024 | Jul 8, 2024 |
| PRE 14A | Preliminary proxy statement | May 10, 2024 | May 10, 2024 |
| DEFA14A | Additional proxy material | May 1, 2024 | — |
| DEF 14A | Proxy statement | Mar 25, 2024 | Apr 30, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 13, 2024 | Apr 30, 2024 |
| DEFA14A | Additional proxy material | Sep 1, 2023 | — |
| DEF 14A | Proxy statement | Aug 24, 2023 | Sep 29, 2023 |
| PRE 14A | Preliminary proxy statement | Aug 10, 2023 | Sep 20, 2023 |
| DEF 14A | Proxy statement | Mar 31, 2023 | Apr 26, 2023 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALZN (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- DE
- Headquarters
- Atlanta, GA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1677077
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.